RF ablation balloon catheters

Barrx™ 360 express RFA balloon catheter

RF ablation balloon catheters

Barrx™ 360 express RFA balloon catheter

The Barrx™ 360 express RFA balloon catheter features a self-adjusting ablation balloon that inflates to the size of the patient’s esophagus.

Description

Easy, efficient circumferential ablation

Eliminate the sizing process during circumferential ablation with the Barrx™ 360 express RFA balloon catheter. This custom-fitting balloon catheter removes the need to choose the right size catheter.

By automatically inflating to the proper size based on the patient’s esophagus, the Barrx™ 360 express RFA balloon catheter makes treatment more efficient: 

  • Reduces procedure time by up to 20†,1,2
  • Reduces time under anesthesia for the patient

 

Features

General characteristics and compatibility

Part number 64082
Electrode length 4 cm
Balloon length 8 cm
Device diameter range 18–31 mm
Balloon max pressure 4 psi
Generator compaitibility Barrx™ flex RFA energy generator only
Number of ablations 16
Generator energy setting 10J/cm2
Guidewire compatibility Stiff wire, .035"–.039" in diameter
Expiration 6 hours after first inflation, 3-year shelf life

Ordering information

Item number Description Units per box
64082 Barrx™ RFA self-sizing balloon catheter 1

Related links

Capsule Endoscopy System Tech Support Promo Box

Technical support

Get technical support for all gastrointestinal and hepatology products.

Email us
Phone
: 1-800-448-3644, option 3

Capsule Endoscopy System Reimbursement Promo Box

Reimbursement

Find reimbursement guides that detail the full range of reimbursement services we offer.

Email us
Phone
: 1-888-389-5200, option 1


When compared to using the Barrx 360 RFA balloon catheter and Barrx 360 soft-sizing balloon.


  1. Based on comparison of average total operation time reported in B550 and SURF randomized clinical trials. Data on file, 2016.
  2. Phoa N, van Vilsteren F, Weusten B, et al. Radiofrequency ablation versus endoscopic surveillance for patients with Barrett's esophagus and low-grade dysplasia–a randomized clinical trial. JAMA. 2014;311(12):1209–1217.